Adeona Pharmaceuticals Inc. has swapped bosses as it continues testing new drugs for multiple sclerosis, fibromyalgia and Lou Gehrig’s disease. It’s also considering a new business focus and a name change.
Pharma startup Adeona and its research partner report no safety issues related to high doses of zinc to slow the effects of Lou Gehrig’s Disease
The pharma startup Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of innovative medicines for serious central nervous system diseases, reported its third quarter 2011 financial results Monday.
Hundreds of people across southeast Michigan are going to “Walk and Roll” for ALS on Sunday at Kensington Metropark in Milford and Stony Creek Metropark in Shelby Township.
Ann Arbor-based Adeona Pharmaceuticals Inc. (AMEX: AEN), a developer of medicines for serious central nervous system diseases, Monday reported its second quarter financial results for the period ended June 30, as well as updates since the beginning of the second quarter.
More news on clinical trials for stem cell cures for some of mankind’s most dreaded diseases emerged Tuesday from the World Stem Cell Summit in Detroit. Thomas Okarma, president and CEO of Menlo Park, Calif.-based […]
Stem cell skeptics have been asking for years, where are the cures? Well, stick around. Spectacular cures may be coming soon, and they have a University of Michigan connection.
In cells, as in cities, disposing of garbage and recycling anything that can be reused is an essential service. In both city and cell, health problems can arise when the process breaks down. New research […]